Showing results (81-90 of 121) with videos related to
Sort By:
Pageof 13
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
Evaluation of COVID-19 vaccination strategies with a delayed second doseSeyed M Moghadas, Thomas N Vilches, Kevin Zhang, et al.Plos Biology|April 21, 2021
Evaluation of COVID-19 vaccination strategies with a delayed second doseSeyed M Moghadas, Thomas N Vilches, Kevin Zhang, et al.Proceedings of the National Academy of Sciences of the United States of America|July 8, 2020
The implications of silent transmission for the control of COVID-19 outbreaksSeyed M Moghadas, Meagan C Fitzpatrick, Pratha Sah, et al.Scientific Reports|July 21, 2017
Asymptomatic Transmission and the Dynamics of Zika InfectionSeyed M Moghadas, Affan Shoukat, Aquino L Espindola, et al.Nature Medicine|January 9, 2025
Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adultsZhanwei Du, Abhishek Pandey, Seyed M Moghadas, et al.Vaccine|February 17, 2024
Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) studyAffan Shoukat, Carolyn E Bawden, Gergely Röst, et al.Proceedings. Biological Sciences|May 18, 2007
Emergence of drug resistance: implications for antiviral control of pandemic influenzaMurray E Alexander, Christopher S Bowman, Zhilan Feng, et al.Eclinicalmedicine|May 3, 2021
Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variantsPratha Sah, Thomas N Vilches, Seyed M Moghadas, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2023
Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United StatesSeyed M Moghadas, Affan Shoukat, Carolyn E Bawden, et al.Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Cost-Effectiveness of Prefusion F Protein-Based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United StatesSeyed M Moghadas, Affan Shoukat, Carolyn E Bawden, et al.Pageof 13